A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma

NCT03585725 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped low accrual

Conditions

Follicular Lymphoma
Mantle Cell Lymphoma

Interventions

DRUG: Ribavirin

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]